Tag: liraglutide

Pharmac Extends Consultation on Diabetes Medicine Access Changes, Proposing Wider Access and Removal of Ethnicity-Based Criteria

11 Jun 2026 8:31 a.m. · Source: Te Pāti Māori

Pharmac has extended its consultation until June 11, 2026, on proposed changes to type 2 diabetes medicine access. The plan aims to widen access by lowering cardiovascular risk criteria but removes specific provisions for Māori and Pacific people.

Health Politics and Government Medical Science General Politics Social Issues Legal Pharmac Type 2 Diabetes Empagliflozin Liraglutide Dulaglutide Health Policy Consultation Te Pāti Māori Maori Election
Pharmac Proposes Wider Access to Type 2 Diabetes Medicines in New Zealand

15 May 2026 7:35 a.m. · Source: New Zealand Government

Pharmac's proposal aims to expand access to three key type 2 diabetes medicines by removing ethnicity criteria and lowering risk thresholds. This change, welcomed by ministers, could benefit thousands of New Zealanders, improving health outcomes and reducing hospital admissions.

Health Politics and Government Medical Science General Politics Social Issues Economy Pharmac Type 2 Diabetes Medicines Healthcare Empagliflozin Liraglutide New Zealand Government